Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
This chapter will:
Review the principles of continuous renal replacement therapy.
Discuss the practical application of continuous renal replacement therapy and the consequences of such application.
Examine the consequences of technical modifications to continuous renal replacement therapy.
Provide information pertaining to choices and prescription of continuous renal replacement therapy.
Endogenous toxins accumulate in blood as a result of many biochemical processes. If their concentration exceeds certain levels, they cause illness. Some toxins are volatile (CO 2 , ketones) and can be excreted by the lungs through ventilation, others are lipophilic (bile acids, bilirubin) and can be excreted by the liver via the biliary system, and others are water soluble and nonvolatile and are excreted by the kidneys ( Table 166.1 ). When the kidneys fail acutely, removal of such water-soluble toxins requires acute artificial renal replacement therapy (RRT).
TOXIN | ROUTE |
---|---|
CO 2 | Lung |
Other volatile toxins | Lung |
Ketones | Lung and kidney |
Bilirubin | Liver and kidney |
Biliary acids | Liver |
Fat-soluble toxins | Liver and (after conjugation) kidney |
Urea | Kidney |
Water-soluble toxins | Kidney |
Water-soluble toxins exist in blood at various concentrations. Blood is a complex fluid containing cells and plasma. Plasma is a complex solution, and it is the plasma compartment of blood that is available for purification by RRT. Plasma contains myriad solutes (electrolytes, proteins, lipids, carbohydrates, vitamins, amino acids), which are dissolved in plasma water (the solvent). Only those solutes that are water soluble and not protein bound (free solutes) are available for removal by classic RRT. This is because the conventional biosynthetic membranes used for RRT have an in vivo cutoff point of about 15 to 20 kilodaltons (kD), which does not allow the passage of anything beyond small proteins (such as β 2 -microglobulin). Accordingly, the following discussion of blood purification principles and techniques relates to free solutes of relatively small to small-medium molecular weight (<15 kD). The chapter does not discuss peritoneal dialysis, in which the dialyzing membrane is the peritoneum and some larger proteins are removed during the blood purification process. Also not discussed in this chapter are different forms of plasma therapies in which protein-bound solutes can be removed through high-porosity membranes.
Extracorporeal techniques are broadly named RRT and include continuous or intermittent hemofiltration, hemodialysis, or hemodiafiltration, each with its own technical variations. All of these techniques rely on the principle of removing unwanted solutes and water through a membrane separation process.
The principles of RRT have been studied extensively and described. This section provides a summary of some technical aspects of RRT, which are particularly relevant for the critical care physician.
The removal of excess solvent (water) is therapeutically at least as important as the removal of unwanted solutes (e.g., acid, uremic toxins, potassium). During RRT, water is removed through a process called ultrafiltration . This process is essentially the same as that performed by the glomerulus. It requires a pressure gradient (generated by blood flow and circuit resistance) to move water across a semipermeable membrane. This is because plasma water normally would be kept within the circulation because of oncotic pressure. This ultrafiltration is achieved by generating a positive hydrostatic pressure (as in hemofiltration or during intermittent hemodialysis) that is greater than oncotic pressure. The final result is a positive transmembrane pressure that drives fluid through the membrane at a rate dependent on the hydraulic permeability coefficient and the surface of the membrane.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here